Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

3,555 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Imidazopyridine derivatives as potent and selective Polo-like kinase (PLK) inhibitors.
Sato Y, Onozaki Y, Sugimoto T, Kurihara H, Kamijo K, Kadowaki C, Tsujino T, Watanabe A, Otsuki S, Mitsuya M, Iida M, Haze K, Machida T, Nakatsuru Y, Komatani H, Kotani H, Iwasawa Y. Sato Y, et al. Among authors: sugimoto t. Bioorg Med Chem Lett. 2009 Aug 15;19(16):4673-8. doi: 10.1016/j.bmcl.2009.06.084. Epub 2009 Jun 25. Bioorg Med Chem Lett. 2009. PMID: 19589677
TAS-119, a novel selective Aurora A and TRK inhibitor, exhibits antitumor efficacy in preclinical models with deregulated activation of the Myc, β-Catenin, and TRK pathways.
Miura A, Sootome H, Fujita N, Suzuki T, Fukushima H, Mizuarai S, Masuko N, Ito K, Hashimoto A, Uto Y, Sugimoto T, Takahashi H, Mitsuya M, Hirai H. Miura A, et al. Among authors: sugimoto t. Invest New Drugs. 2021 Jun;39(3):724-735. doi: 10.1007/s10637-020-01019-9. Epub 2021 Jan 6. Invest New Drugs. 2021. PMID: 33409897
Cutoffs on severity metrics for minimal manifestations or better status in patients with generalized myasthenia gravis.
Watanabe G, Takai Y, Nagane Y, Kubota T, Yasuda M, Akamine H, Onishi Y, Uzawa A, Kawaguchi N, Masuda M, Konno S, Amino I, Minami N, Kimura T, Samukawa M, Sugimoto T, Suzuki Y, Takahashi MP, Suzuki S, Murai H, Aoki M, Utsugisawa K. Watanabe G, et al. Among authors: sugimoto t. Front Immunol. 2024 Dec 23;15:1502721. doi: 10.3389/fimmu.2024.1502721. eCollection 2024. Front Immunol. 2024. PMID: 39763650 Free PMC article.
Invasive mucinous adenocarcinoma harbored MET exon 14 skipping mutation: case report.
Washioka A, Akamatsu H, Sugimoto T, Kitahara D, Kaki T, Murakami E, Hayata A, Iwamoto R, Yamamoto N. Washioka A, et al. Among authors: sugimoto t. Transl Lung Cancer Res. 2024 Nov 30;13(11):3252-3255. doi: 10.21037/tlcr-24-449. Epub 2024 Nov 12. Transl Lung Cancer Res. 2024. PMID: 39669996 Free PMC article.
3,555 results